Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism EGFR modulators(Epidermal growth factor receptor erbB1 modulators), HER2 modulators(Receptor protein-tyrosine kinase erbB-2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Irritable Bowel Syndrome | Preclinical | - | 29 Dec 2022 |